Essential Regulatory Solutions

Antigen Discovery Inc, based in Irvine, California, is a leading provider of customized solutions in the field of proteome research. With their advanced proteome microarray technology and high-throughput T cell screening applications, they offer a wide range of services including protein microarrays, autoantibody biomarkers, antibody target verification, ligand binding assays, ELISA analytical services, and more. Driven by their mission to unlock the power of the proteome, Antigen Discovery Inc is dedicated to providing innovative solutions for the study of bacteria, viruses, protozoa, and the human proteome. With a strong leadership team and partnerships with various organizations, they cater to the needs of their customers and strive to advance the field of proteome research.Generated from the website

Founded in 1988, 3E Company is a privately held company that offers a range services for environmental, health and safety (EH&S) related chemical and hazardous materials information and compliance management. The company provides data products and information services. It offers regulatory research, distribution and management, transportation, emergency response, training, regulatory reporting and hazardous waste management services. 3E Company staffs regulatory specialists, product stewards, industrial hygienists, attorneys, chemists, chemical engineers and consultants. The company has partnerships with Costco Wholesale Corporation, America West, Eastman Chemical, Temple-Inland, Menasha and PacifiCorp. Additionally, 3E Company acts as a third-party representative and provides several professional services. The company serves clients from the manufacturing, distribution, transportation and health care industries.

AutoGenomics, based in Vista, CA, is a leading provider of fully integrated systems for clinical laboratories, offering a wide range of automated, cost-effective, and user-friendly tests with exceptional accuracy and sensitivity. Their INFINITI system, designed specifically for their proprietary BioFilmChip microarrays, allows for multiplexing and configuration with hundreds of biomarkers, enabling the assessment of disease signatures from a single sample specimen. With a focus on empowering healthcare professionals, AutoGenomics aims to uncover critical insights that enhance patient care and prevention, utilizing their expertise in various fields to develop powerful tests, instruments, and analytics that provide actionable results for more informed decision-making. AutoGenomics is dedicated to revolutionizing healthcare by providing clinical laboratories with advanced technologies that improve productivity, workflow, and cost per reportable result. Their comprehensive approach, combining expertise in pharmacology, chemistry, pathology, pharmacogenomics, and toxicology, enables the delivery of accurate and timely information to physicians, allowing for better prescription choices and predictions of patient reactions to potential treatments. With a strong commitment to innovation and a focus on the future, AutoGenomics is poised to shape the next frontier in healthcare, addressing critical needs with their ready-to-use technology and unwavering passion.Generated from the website